| 1 |
29728928 | Effects of diltiazem, a moderate inhibitor of CYP3A4, on the pharmacokinetics of tamsulosin in different CYP2D6 genotypes. | 2018 May |
1 |
| 2 |
23700791 | Effects of CYP3A5 and CYP2D6 genetic polymorphism on the pharmacokinetics of diltiazem and its metabolites in Chinese subjects. | 2013 Apr |
3 |
| 3 |
17574934 | Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake: use as adulterant of cocaine resulting in drug-drug interactions? | 2007 Aug 15 |
1 |
| 4 |
15863898 | Inhibitory effects of nicardipine to cytochrome P450 (CYP) in human liver microsomes. | 2005 May |
1 |
| 5 |
11744603 | Desacetyl-diltiazem displays severalfold higher affinity to CYP2D6 compared with CYP3A4. | 2002 Jan |
5 |
| 6 |
12235455 | Pharmacokinetics of diltiazem and its metabolites in relation to CYP2D6 genotype. | 2002 Sep |
3 |
| 7 |
11151747 | CYP2D6 is involved in O-demethylation of diltiazem. An in vitro study with transfected human liver cells. | 2000 Nov |
8 |